These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Hearing function after betahistine therapy in patients with Ménière's disease. Seyed Tootoonchi SJ; Ghiasi S; Shadara P; Samani SM; Fouladi DF Braz J Otorhinolaryngol; 2016; 82(5):500-6. PubMed ID: 26810620 [TBL] [Abstract][Full Text] [Related]
46. Management of Ménière's disease in general practice: adherence to the UK National Health Service 'Prodigy' guidelines. Smale E; McDonald S; Maha N; Short S J Laryngol Otol; 2008 Aug; 122(8):780-5. PubMed ID: 18039416 [TBL] [Abstract][Full Text] [Related]
47. Modification of the vestibular function with betahistine HCl. Bertrand RA Laryngoscope; 1971 Jun; 81(6):889-98. PubMed ID: 4997046 [No Abstract] [Full Text] [Related]
48. The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Ménière's disease. Liu JL; Liu JG; Chen XB; Liu YH J Laryngol Otol; 2020 Dec; 134(12):1073-1076. PubMed ID: 33280619 [TBL] [Abstract][Full Text] [Related]
49. Report from a Consensus Conference on the treatment of Ménière's disease with betahistine: rationale, methodology and results. Casani AP; Guidetti G; Schoenhuber R; Acta Otorhinolaryngol Ital; 2018 Oct; 38(5):460-467. PubMed ID: 30498275 [TBL] [Abstract][Full Text] [Related]
51. Is Betahistine Effective in the Treatment of Ménière's Disease? Holmes S; Lalwani AK; Mankekar G Laryngoscope; 2021 Dec; 131(12):2639-2640. PubMed ID: 33755198 [No Abstract] [Full Text] [Related]
52. [Drug information. Therapeutic main group: agents for the treatment of vertigo. Behahistine (Betaserc)]. Lumholtz IB Sygeplejersken; 1979 Apr; 79(14):19. PubMed ID: 256278 [No Abstract] [Full Text] [Related]
53. "How should a treatment of Méniére's syndrome be evaluated?" Panel discussion. Acta Otolaryngol Suppl; 1972; 305():80-99. PubMed ID: 4146950 [No Abstract] [Full Text] [Related]
54. Betahistine or Cinnarizine for treatment of Meniere's disease. Djelilovic-Vranic J; Alajbegovic A; Tiric-Campara M; Volic A; Sarajlic Z; Osmanagic E; Todorovic L; Beslagic O Med Arch; 2012; 66(6):396-8. PubMed ID: 23409520 [TBL] [Abstract][Full Text] [Related]
55. [Treatment of Meniere's disease: conservative or operative]. Beck C; Arnold W; Lange G; Rudert H; Scherer H Laryngol Rhinol Otol (Stuttg); 1985 Dec; 64(12):601-3. PubMed ID: 4087990 [No Abstract] [Full Text] [Related]
56. Using betahistine in the treatment of patients with Menière's disease: a meta-analysis with the current randomized-controlled evidence. Devantier L; Hougaard D; Händel MN; Liviu-Adelin Guldfred F; Schmidt JH; Djurhuus B; Callesen HE Acta Otolaryngol; 2020 Oct; 140(10):845-853. PubMed ID: 32580600 [No Abstract] [Full Text] [Related]
57. Betahistine for Menière's disease or syndrome. James AL; Burton MJ Cochrane Database Syst Rev; 2001; 2001(1):CD001873. PubMed ID: 11279734 [TBL] [Abstract][Full Text] [Related]
58. [The use of betaserk in patients with cochlear-vestibular disorders]. Kadymov MI; Poliakova TS; Vladimirova TN Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432 [TBL] [Abstract][Full Text] [Related]